The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy
- 24 May 2010
- journal article
- Published by Wiley in BJU International
- Vol. 105 (12) , 1646-1649
Abstract
Study Type – Therapy (case series) Level of Evidence 4 OBJECTIVES: To evaluate the effects of age at radical prostatectomy (RP) on recurrence‐free survival (RFS) in patients with prostate cancer stratified by established preoperative risk factors (such as prostate‐specific antigen (PSA) level, Gleason score, and tumour stage), as increasing age has been associated with more indolent behaviour in some cancers. PATIENTS AND METHODS: A retrospective analysis of men treated with RP from 1988 to 2008 was conducted. Patients were divided into two groups by age at the time of RP, and RFS rates were analysed using Kaplan–Meier survival curves. The subgroups were stratified by preoperative PSA level, biopsy Gleason score, and clinical stage; multivariate analyses with Cox proportional hazards models were used to identify independent predictors of recurrence. Recurrence was defined as a single PSA level of ≥0.2 ng/mL at least 28 days after RP. RESULTS: In all, 1984 patients met inclusion criteria and were divided into groups 1 (1325 men aged 40–64 years) and 2 (659 men aged ≥65 years). The 5‐year RFS rates were 80.6% (confidence interval, CI 78.0–82.9%) and 75.6% (CI 71.5–79.1%) for groups 1 and 2, respectively. In the univariate model, advanced age was significantly associated with an increased overall risk of recurrence (hazard ratio, HR 1.30, P = 0.012). However, in multivariate analyses accounting for PSA level, Gleason score, and clinical stage, age was not an independent predictor of recurrence (HR 1.04, P = 0.76). CONCLUSION: Older patients who undergo RP appear to have an increased risk of recurrence. However, age is not an independent predictor of recurrence when accounting for PSA level, grade, and stage.Keywords
This publication has 9 references indexed in Scilit:
- Prostate‐specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 yearsBJU International, 2007
- The Effect of Age on Prostate Implantation ResultsThe Cancer Journal, 2006
- Is preoperative serum prostate‐specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?BJU International, 2005
- PREOPERATIVE MODEL FOR PREDICTING PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY USING PERCENT OF BIOPSY TISSUE WITH CANCER, BIOPSY GLEASON GRADE AND SERUM PROSTATE SPECIFIC ANTIGENJournal of Urology, 2004
- Predicting Recurrence After Radical Prostatectomy for Patients With High Risk Prostate CancerJournal of Urology, 2003
- Biochemical Disease-Free Survival in Men Younger Than 60 Years With Prostate Cancer Treated With External Beam RadiationJournal of Urology, 2002
- LONG-TERM SURVIVAL AFTER RADIOTHERAPY ALONE: RADIATION THERAPY ONCOLOGY GROUP PROSTATE CANCER TRIALSJournal of Urology, 1999
- A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate CancerJNCI: Journal of the National Cancer Institute, 1998
- Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancerUrology, 1996